CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

PR Newswire Clinical Trials
Original article

Xenograft Model Selection and Standardization Across CDX, PDX, Humanized, and Organoid-Derived Models in Preclinical Cancer Research

Neutral
AI Analysis

Summary

Altogen Labs published a comprehensive framework for xenograft model selection and standardization in JoVE, providing guidance for preclinical oncology program design from early efficacy through IND-enabling safety studies.

Importance:2/10
Sentiment:
0.00
preclinical researchxenograft modelsCDXPDXhumanized modelsorganoid modelsoncologyframework publication
Related Companies

Read the original article

Published by PR Newswire Clinical Trials on August 31, 2026 2:30 PM

Read Original